What is Olema Pharmaceuticals Inc (OLMA) stock price today?

Olema Pharmaceuticals Inc (OLMA) currently trades at $14.14 per share. The stock has a market capitalization of $1.23B and a P/E ratio of —x.

Is OLMA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Olema Pharmaceuticals Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is 4.24.

Is Olema Pharmaceuticals Inc financially healthy?

Olema Pharmaceuticals Inc's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of 4.24 places it in the safe zone.

OLMA

Olema Pharmaceuticals Inc

NASDAQ: OLMA · HEALTHCARE · BIOTECHNOLOGY

$14.14

-3.08% today

Updated 2026-04-29

Market cap

$1.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.87

Dividend yield

—

52W range

$4 – $36

Volume

1.6M

Market cap

$1.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.87

Dividend yield

—

52W range

$4 – $36

Volume

1.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

4.2

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$43.00

+204.10%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy10 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 4.24 — safe zone

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-38.33M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-102.59M	$-96.66M	$-129.47M	$-162.45M	$-46.06M
EPS	—	—	—	—	$-1.87
Free cash flow	$-82.43M	$-83.73M	$-104.51M	$-146.72M	$-38.33M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OLMA	$1.23B	28	4.3	3.0	5.0	7.3	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Olema Pharmaceuticals Inc trades at $14.14. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 4.24, it sits in the safe zone.

Frequently asked questions

What is Olema Pharmaceuticals Inc's stock price?

Olema Pharmaceuticals Inc (OLMA) trades at $14.14.

Is Olema Pharmaceuticals Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of Olema Pharmaceuticals Inc (OLMA)?

The analyst target price is $43.00, representing +204.1% upside from the current price of $14.14.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

4.24 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-36.60%

Beta2.18

50D MA$17.48

200D MA$15.77

Shares out0.09B

Float0.07B

Short ratio—

Avg volume1.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OLMA vs LLY →OLMA vs JNJ →OLMA vs ABBV →Stock screener →